文献速递其他结缔组织病

系统性硬化症中的心血管与静脉血栓栓塞事件:基于临床实践研究数据链的流行病学分析

Cardiovascular and venous thromboembolic events in systemic sclerosis: epidemiological analysis of the Clinical Practice Research Datalink.
PubMed 文献 · Rheumatology (Oxford) · 2025-01-01

基于临床实践研究数据链(CPRD)的队列研究,将877例新发系统性硬化症(SSc)患者按1:6匹配至5262例非SSc对照,平均随访8年。SSc患者基线与随访期间冠状动脉疾病、外周动脉疾病、外周静脉血栓及肺栓塞风险显著升高(校正风险比1.84–3.01),男性尤为明显;脑血管疾病风险未见升高。

要点

  • SSc患者诊断前及诊断后8年内动脉与静脉血栓事件风险均升高。
  • 冠状动脉疾病、外周动脉疾病、外周静脉血栓和肺栓塞的校正风险比为1.84–3.01。
  • 脑血管疾病风险未见升高;男性风险尤为突出。

核心结论

  • SSc患者诊断前及诊断后8年内发生心血管事件和静脉血栓栓塞的风险增加。
  • 需要开展工作以明确SSc中动脉与静脉血栓事件的机制,从而制定更有针对性的预防策略并改善结局。

研究设计与样本

  • 采用经验证的病例确认策略在临床实践研究数据链(CPRD)中识别SSc患者。
  • 队列研究设计,将SSc患者按年龄、性别和地点以1:6比例匹配至非SSc对照,分别分析SSc的患病与发病病例。
  • 采用Cox回归分析计算事件发生的风险比,并校正传统心血管危险因素。
  • 识别877例符合条件的新发SSc病例,匹配5262例非SSc患者(83.7%为女性),平均随访8年。

主要发现

  • SSc队列在基线时(早于诊断)冠状动脉疾病、外周动脉疾病和静脉血栓栓塞的背景患病率较高。
  • 随访期间SSc患者相较非SSc组冠状动脉疾病、外周动脉疾病、外周静脉血栓和肺栓塞风险显著升高(校正风险比1.84–3.01),男性中尤为明显。
  • 脑血管疾病风险未见升高。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Cardiovascular disease is a leading cause of mortality in systemic sclerosis (SSc). We investigated the association between SSc and the occurrence of both cardiovascular and thromboembolic events using the Clinical Practice Research Datalink (CPRD). METHODS: A validated case-ascertainment strategy identified SSc patients in the CPRD. A cohort study design examined rates of coronary arterial disease (CAD), cerebrovascular disease, peripheral artery disease (PAD) and venous thromboembolism (VTE) in SSc patients matched to non-SSc comparators by age, sex and location in a 1:6 ratio. Prevalent and incident cases of SSc were analysed separately. Cox regression analysis was used to determine hazard ratios for event occurrence, adjusted for traditional cardiovascular risk factors. RESULTS: We identified 877 eligible incident cases of SSc who were matched to 5262 patients without SSc (83.7% female), with a mean follow-up of 8 years. We identified a higher background prevalence of CAD, PAD and VTE at baseline (pre-dating diagnosis) in the SSc cohort. There was a significantly increased risk of CAD, PAD, peripheral venous thromboses and pulmonary embolism during follow-up in SSc compared with the non-SSc group (adjusted hazard ratios between 1.84-3.01), particularly amongst males. There was no increased risk of cerebrovascular disease. CONCLUSIONS: We have identified an increased risk of cardiovascular events and VTE, both prior to a diagnosis of SSc and within 8 years of SSc diagnosis. Work is needed to establish the mechanism of arterial/venous thrombotic events in SSc. This insight will facilitate more targeted and effective preventative strategies and improve outcomes in SSc.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Pauling JD, Charlton R, Ross L, et al. Cardiovascular and venous thromboembolic events in systemic sclerosis: epidemiological analysis of the Clinical Practice Research Datalink. Rheumatology (Oxford). 2025. PMID: 40445198. doi:10.1093/rheumatology/keaf285

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。